Rabeprazole Sodium/Sodium Bicarbonate

雷贝拉唑钠/碳酸氢钠

Report date: 2026/02/05 11:43:12

Base Information

Drug NameRabeprazole Sodium/Sodium Bicarbonate
Drug Alias NameRABEDUO
ClassificationSmall molecules
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsStomach UlcerDuodenal UlcerGastroesophageal Reflux
Global Approved IndicationsStomach UlcerDuodenal UlcerGastroesophageal Reflux
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2022/01/28
Country/TerritorySouth Korea
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKorea United Pharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesKorea United Pharm Inc
Inactive CompaniesN/A
Active IndicationsStomach UlcerDuodenal UlcerGastroesophageal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A